These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. The strategy, organization, and progress of the HUPO Human Proteome Project. Omenn GS J Proteomics; 2014 Apr; 100():3-7. PubMed ID: 24145142 [TBL] [Abstract][Full Text] [Related]
6. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836 [TBL] [Abstract][Full Text] [Related]
7. Chemical coverage of human biological pathways. Kwak HA; Liu L; Tredup C; Röhm S; Prinos P; Böttcher J; Schapira M Drug Discov Today; 2024 Oct; 29(10):104144. PubMed ID: 39179147 [TBL] [Abstract][Full Text] [Related]
8. ChemBioPort: an online portal to navigate the structure, function and chemical inhibition of the human proteome. Liu L; Rovers E; Schapira M Database (Oxford); 2022 Sep; 2022():. PubMed ID: 36164975 [TBL] [Abstract][Full Text] [Related]
9. Translating the Genome into Drugs. Dixit A; Barhoosh H; Paegel BM Acc Chem Res; 2023 Feb; 56(4):489-499. PubMed ID: 36757774 [TBL] [Abstract][Full Text] [Related]
10. Making the Case for Functional Proteomics. Perkins RC Methods Mol Biol; 2019; 1871():1-40. PubMed ID: 30276729 [TBL] [Abstract][Full Text] [Related]
11. The quest of the human proteome and the missing proteins: digging deeper. Reddy PJ; Ray S; Srivastava S OMICS; 2015 May; 19(5):276-82. PubMed ID: 25933256 [TBL] [Abstract][Full Text] [Related]
13. Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. Ayoubi R; Ryan J; Biddle MS; Alshafie W; Fotouhi M; Bolivar SG; Ruiz Moleon V; Eckmann P; Worrall D; McDowell I; Southern K; Reintsch W; Durcan TM; Brown C; Bandrowski A; Virk H; Edwards AM; McPherson P; Laflamme C Elife; 2023 Nov; 12():. PubMed ID: 37995198 [TBL] [Abstract][Full Text] [Related]
14. Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome. Özdemir V; Dove ES; Gürsoy UK; Şardaş S; Yıldırım A; Yılmaz ŞG; Ömer Barlas I; Güngör K; Mete A; Srivastava S J Neural Transm (Vienna); 2017 Jan; 124(1):25-32. PubMed ID: 26645377 [TBL] [Abstract][Full Text] [Related]
15. Public resources for chemical probes: the journey so far and the road ahead. Antolin AA; Workman P; Al-Lazikani B Future Med Chem; 2021 Apr; 13(8):731-747. PubMed ID: 31778323 [TBL] [Abstract][Full Text] [Related]
16. Chemical genomics: bridging the gap between the proteome and therapeutics. Falb D; Jindal S Curr Opin Drug Discov Devel; 2002 Jul; 5(4):532-9. PubMed ID: 12197311 [TBL] [Abstract][Full Text] [Related]
17. Target Identification Using Chemical Probes. Moustakim M; Felce SL; Zaarour N; Farnie G; McCann FE; Brennan PE Methods Enzymol; 2018; 610():27-58. PubMed ID: 30390803 [TBL] [Abstract][Full Text] [Related]
18. Genomics and bioinformatics of Parkinson's disease. Scholz SW; Mhyre T; Ressom H; Shah S; Federoff HJ Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a009449. PubMed ID: 22762024 [TBL] [Abstract][Full Text] [Related]